ATE405669T1 - Remodellierung von glycoproteinen unter verwendung von endoglycanasen - Google Patents

Remodellierung von glycoproteinen unter verwendung von endoglycanasen

Info

Publication number
ATE405669T1
ATE405669T1 AT02786845T AT02786845T ATE405669T1 AT E405669 T1 ATE405669 T1 AT E405669T1 AT 02786845 T AT02786845 T AT 02786845T AT 02786845 T AT02786845 T AT 02786845T AT E405669 T1 ATE405669 T1 AT E405669T1
Authority
AT
Austria
Prior art keywords
glycoproteins
endoglycanases
remodeling
provides methods
recombinantly produced
Prior art date
Application number
AT02786845T
Other languages
English (en)
Inventor
Shawn Defrees
Karl Johnson
Original Assignee
Neose Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neose Technologies Inc filed Critical Neose Technologies Inc
Application granted granted Critical
Publication of ATE405669T1 publication Critical patent/ATE405669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT02786845T 2001-11-28 2002-11-27 Remodellierung von glycoproteinen unter verwendung von endoglycanasen ATE405669T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33430101P 2001-11-28 2001-11-28

Publications (1)

Publication Number Publication Date
ATE405669T1 true ATE405669T1 (de) 2008-09-15

Family

ID=23306575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02786845T ATE405669T1 (de) 2001-11-28 2002-11-27 Remodellierung von glycoproteinen unter verwendung von endoglycanasen

Country Status (7)

Country Link
EP (1) EP1461445B1 (de)
JP (1) JP2005535280A (de)
AT (1) ATE405669T1 (de)
AU (1) AU2002351199A1 (de)
CA (1) CA2468295C (de)
DE (1) DE60228492D1 (de)
WO (1) WO2003046150A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
JP2006523211A (ja) 2003-03-14 2006-10-12 ネオス テクノロジーズ インコーポレイテッド 分岐水溶性ポリマーとその複合物
NZ542586A (en) 2003-04-09 2009-11-27 Biogenerix Ag Method of forming a covalent conjugate between a G-CSF peptide and PEG
AU2004240553A1 (en) 2003-05-09 2004-12-02 Neose Technologies, Inc. Compositions and methods for the preparation of human growth hormone glycosylation mutants
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US7338933B2 (en) 2004-01-08 2008-03-04 Neose Technologies, Inc. O-linked glycosylation of peptides
KR20070008645A (ko) 2004-05-04 2007-01-17 노보 노르디스크 헬스 케어 악티엔게젤샤프트 폴리펩티드의 ｏ-연결된 단백당형 및 그들의 제조 방법
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
EP1799249A2 (de) 2004-09-10 2007-06-27 Neose Technologies, Inc. Glycopegyliertes interferon alpha
EP1797192A1 (de) * 2004-09-29 2007-06-20 Novo Nordisk Health Care AG Modifizierte proteine
EP3061461A1 (de) 2004-10-29 2016-08-31 ratiopharm GmbH Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US8148112B2 (en) * 2005-02-16 2012-04-03 National University Corporation Hokkaido University Sugar chain containing 4-position halogenated galactose and application thereof
EP1871795A4 (de) 2005-04-08 2010-03-31 Biogenerix Ag Zusammensetzungen und verfahren zur herstellung von glycosylierungsmutanten eines proteaseresistenten menschlichen wachstumshormons
WO2006127910A2 (en) 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated erythropoietin formulations
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
WO2008029281A2 (en) 2006-02-10 2008-03-13 Invitrogen Corporation Labeling and detection of post translationally modified proteins
US20080242607A1 (en) 2006-07-21 2008-10-02 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
AU2007333049B2 (en) 2006-12-15 2014-02-20 Takeda Pharmaceutical Company Limited Factor VIIa-(poly)sialic acid conjugate having prolonged in vivo half-life
CN101796063B (zh) 2007-04-03 2017-03-22 拉蒂奥法姆有限责任公司 使用糖聚乙二醇化g‑csf的治疗方法
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
DK2257311T3 (da) 2008-02-27 2014-06-30 Novo Nordisk As Konjugerede Faktor VIII-Molekyler
AU2009279062B2 (en) 2008-08-08 2014-01-16 Universiteit Gent Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof
PL2889043T3 (pl) * 2008-12-16 2019-09-30 Genzyme Corporation Syntetyczne związki pośrednie do wytwarzania koniugatów oligosacharyd-białko
AU2010229675B2 (en) 2009-03-27 2016-02-25 Academia Sinica Methods and compositions for immunization against virus
RU2744370C2 (ru) 2009-07-27 2021-03-05 Баксалта Инкорпорейтед Конъюгаты белков свертывания крови
WO2011012850A2 (en) 2009-07-27 2011-02-03 Lipoxen Technologies Limited Glycopolysialylation of non-blood coagulation proteins
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
US8637640B2 (en) 2009-07-27 2014-01-28 Baxter International Inc. Blood coagulation protein conjugates
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法
PL2654794T3 (pl) 2010-12-22 2020-07-27 Baxalta GmbH Materiały i sposoby sprzęgania rozpuszczalnej w wodzie pochodnej kwasu tłuszczowego z białkiem
US10851174B2 (en) 2011-03-03 2020-12-01 University Of Maryland, Baltimore Core fucosylated glycopeptides and glycoproteins: chemoenzymatic synthesis and uses thereof
EP2812442B9 (de) 2012-02-10 2023-02-15 University of Maryland, Baltimore Chemoenzymatisches glycoengineering von antikörpern und fc-fragmenten davon
CN108026558B (zh) 2015-07-09 2021-08-17 非营利性组织佛兰芒综合大学生物技术研究所 产生具有改变的n-和o-糖基化模式的糖蛋白的细胞及其方法和用途
KR102229037B1 (ko) 2017-09-04 2021-03-17 89바이오 리미티드 돌연변이 fgf-21 펩티드 접합체 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005330A1 (en) 1986-03-07 1987-09-11 Michel Louis Eugene Bergh Method for enhancing glycoprotein stability
US5728554A (en) 1995-04-11 1998-03-17 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US5876980A (en) 1995-04-11 1999-03-02 Cytel Corporation Enzymatic synthesis of oligosaccharides
US6030815A (en) 1995-04-11 2000-02-29 Neose Technologies, Inc. Enzymatic synthesis of oligosaccharides
US5922577A (en) 1995-04-11 1999-07-13 Cytel Corporation Enzymatic synthesis of glycosidic linkages
NZ336780A (en) 1997-01-16 2000-12-22 Neose Technologies Inc In vitro sialylation of glycoproteins
AU2001263149A1 (en) * 2000-05-12 2001-11-26 Neose Technologies, Inc. In vitro fucosylation recombinant glycopeptides

Also Published As

Publication number Publication date
CA2468295A1 (en) 2003-06-05
WO2003046150A2 (en) 2003-06-05
EP1461445A4 (de) 2005-08-17
CA2468295C (en) 2010-08-03
EP1461445A2 (de) 2004-09-29
EP1461445B1 (de) 2008-08-20
DE60228492D1 (de) 2008-10-02
AU2002351199A1 (en) 2003-06-10
JP2005535280A (ja) 2005-11-24
WO2003046150A3 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
DE60228492D1 (de) Remodellierung von glycoproteinen unter verwendung von endoglycanasen
DK1015622T3 (da) Praktisk sialylering in vitro af rekombinante glycoproteiner
MXPA02011016A (es) Glicopeptidos recombinantes de glucolisacion in vitro.
DE69635948D1 (de) Methoden zur modifikation von kohlenhydratanteilen
IL149459A0 (en) Recombinant gelatins
ATE556540T1 (de) Adaptive filterung in abhängigkeit von der blockkantenstärke
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
BRPI0510295A (pt) preparação de uma glicoproteìna, e, método para produzir a mesma
DE60124730D1 (de) Neue methoden unter verwendung von cholinesteraseinhibitoren
BR0206429A (pt) Composição alvejante para a lavagem de roupa, método de branqueamento de um substrato, e, ligando
DE60336956D1 (de) Laserstrahlmaschine
DE60316726D1 (de) Verfahren zur herstellung eines pressfilzes und pressfilz in form einer geschlossenen schleife
WO2003104540A3 (en) Non-woven fabric
DE69915310D1 (de) Methoden zur behandlung der salzabhängigen hypertonie
DK1078063T3 (da) BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis
ATE354802T1 (de) Methoden zum screening knochenmorphogenetishemimetika
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
ATE554426T1 (de) Verfahren zur ermöglichung der übertragung von im wesentlichen gleichen energiemengen
ATE358172T1 (de) Verfahren zur herstellung von olefinen.
DE69913951D1 (de) Verfahren zur hydrophobierung von gips unter verwendung von mindestens eines alkylhydogenpolysiloxans und mindestens eines hydrokolloides
ATE374757T1 (de) Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten
ATE323677T1 (de) Verfahren zur herstellung von 4-amino-2,5- bisheterocyclylchinazolinen
ATE259256T1 (de) Düse zur verdünnung von phosphorwasserstoff
ATE470442T1 (de) Verwendung von gamma-tocotrienol als diuretika
DE50211365D1 (de) Substituierte 1-phenethylpiperidinverbindungen, die unter anderem als analgetika verwendung finden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties